In 2024, the global market for anxiety disorders and depression treatment is valued at approximately USD 18.9 billion and is expected to reach around USD 27.4 billion by 2032. This represents a compound annual growth rate (CAGR) of about 4.7%. Growth is being fueled by the rising global